NCT00001877View on ClinicalTrials.gov

Treatment of Pulmonary Sarcoidosis With Pentoxifylline

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 1999

Study Completion Date

May 31, 2004

Conditions
Pulmonary Sarcoidosis
Interventions
DRUG

Pentoxifylline

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001877 - Treatment of Pulmonary Sarcoidosis With Pentoxifylline | Biotech Hunter | Biotech Hunter